HCLTech has launched a 40,000-square-foot semiconductor laboratory in Bengaluru with a ₹185 crore investment to boost end-to-end chip testing. The facility supports the company's 'Spec2Parts' business model by reducing the need for international validation. HCLTech shares ended slightly lower at ₹1,277 on Tuesday amid general pressure in the IT sector.
HCLTech has officially inaugurated a 40,000-square-foot semiconductor laboratory in Bengaluru, supported by an investment of ₹185 crore. The facility is designed to function as a central hub for post-silicon engineering, which involves advanced testing and validation of chips after they have been designed and manufactured.
This investment is part of HCLTech’s 'Spec2Parts' business model. By creating an integrated space, the company aims to help its global clients manage the entire product lifecycle under one roof. Previously, many companies had to send their chips to international labs for specialized testing and failure analysis, which added time and cost to the production cycle. With 25,000 square feet of specialized cleanroom space, the lab is equipped with precision tools from global suppliers like Teradyne, Advantest, Keysight, Tektronix, and Thermo Fisher Scientific to handle these complex tasks locally.
On the stock market, HCLTech shares closed at ₹1,277 on the NSE on Tuesday, marking a minor decline of approximately 0.45%. This movement occurred alongside broader pressure on the IT sector during the trading session, as investors continue to weigh macroeconomic factors against company-specific developments.
While this facility aims to strengthen HCLTech’s position in the engineering and R&D segment, the sector remains highly competitive. Investors often monitor profit margins in this space, as building and maintaining such capital-intensive labs requires significant ongoing investment. The ultimate success of this facility will depend on how efficiently the company can utilize its capacity and secure demand from global clients who are increasingly looking for localized high-complexity engineering services.
Another point for investors to consider is the cyclical nature of the semiconductor industry. Demand for testing and validation services can fluctuate based on global chip sales and the pace of new product launches by major technology firms. As HCLTech integrates this new capability into its offerings, market participants will likely track how quickly the lab achieves high utilization rates and whether it successfully contributes to the company’s revenue growth in the coming quarters.